Core Binding Factor Acute Myeloid Leukemia

Core Binding Factor Acute Myeloid Leukemia — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-26	311	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab])`	2026-09-26	pubmed
Last 5 years	2021-01-01 → 2026-12-31	121	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-26	pubmed
Preceding 5-year window	2020-09-26 → 2025-09-25	106	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2020/09/26:2025/09/25[dp])`	2026-09-26	pubmed
Last 12 months	2025-09-26 → 2026-09-26	26	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2025/09/26:2026/09/26[dp])`	2026-09-26	pubmed
y2016	2016-01-01 → 2016-12-31	16	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-26	pubmed
y2017	2017-01-01 → 2017-12-31	17	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-26	pubmed
y2018	2018-01-01 → 2018-12-31	14	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-26	pubmed
y2019	2019-01-01 → 2019-12-31	15	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-26	pubmed
y2020	2020-01-01 → 2020-12-31	32	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-26	pubmed
y2021	2021-01-01 → 2021-12-31	29	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-26	pubmed
y2022	2022-01-01 → 2022-12-31	22	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-26	pubmed
y2023	2023-01-01 → 2023-12-31	21	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-26	pubmed
y2024	2024-01-01 → 2024-12-31	20	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-26	pubmed
y2025	2025-01-01 → 2025-12-31	30	`("Core Binding Factor Acute Myeloid Leukemia"[tiab] OR "CBF-AML"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-26	pubmed

Data updated 4 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (7)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–7 of 7 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
· Blood · 1998 · PMID 9746770 · validated civic_curation pubmed
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
· J Clin Oncol · 2005 · PMID 16110030 · validated civic_curation pubmed
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
· J Clin Oncol · 2004 · PMID 15289486 · validated civic_curation pubmed